Georgia Kourlaba

Summary

Affiliation: Harokopio University
Country: Greece

Publications

  1. ncbi request reprint Cost-minimization analysis of the treatment of patients with metastatic colorectal cancer in Greece
    Vassilis Fragoulakis
    National School of Public Health, Department of Health Services Management, Athens, Greece
    Clin Ther 34:2132-42. 2012
  2. ncbi request reprint Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
    Georgia Kourlaba
    The Stavros Niarchos Foundation Collaborative Center for Clinical Epidemiology and Outcomes Research CLEO, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
    BMC Health Serv Res 14:631. 2014
  3. ncbi request reprint Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece
    Georgia Kourlaba
    National School of Public Health, Department of Health Services Management, Athens, Greece
    Appl Health Econ Health Policy 10:331-42. 2012
  4. ncbi request reprint Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis
    Georgia Kourlaba
    National School of Public Health, Department of Health Services Management, Athens, Greece
    Appl Health Econ Health Policy 10:261-71. 2012
  5. pmc Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study
    Thomas Paparrigopoulos
    Athens University Medical School, 1st Department of Psychiatry, Eginition Hospital, Athens, Greece
    BMC Psychiatry 11:41. 2011
  6. pmc Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece
    Nikos Maniadakis
    Department of Health Services Organization and Management, National School of Public Health, 196 Alexandras Avenue, Athens 11521, Greece
    BMC Health Serv Res 13:173. 2013
  7. ncbi request reprint The economic burden of atherothrombosis in Greece: results from the THESIS study
    Nikos Maniadakis
    Department of Health Services Organization and Management, National School of Public Health, 196 Alexandras Avenue 115 21, Athens, Greece
    Eur J Health Econ 14:655-65. 2013
  8. pmc Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece
    Vassilis Fragoulakis
    Department of Health Services Management, National School of Public Health, Athens
    Clinicoecon Outcomes Res 4:185-92. 2012
  9. pmc Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
    Vassilis Fragoulakis
    Department of Health Services and Management, National School of Public Health, Athens, Greece
    Clinicoecon Outcomes Res 4:135-43. 2012
  10. ncbi request reprint Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
    Charalampos Tzanetakos
    Department of Health Services Organisation and Management, National School of Public Health, 196 Alexandras Avenue, 11521 Athens, Greece
    BMC Health Serv Res 14:419. 2014

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Cost-minimization analysis of the treatment of patients with metastatic colorectal cancer in Greece
    Vassilis Fragoulakis
    National School of Public Health, Department of Health Services Management, Athens, Greece
    Clin Ther 34:2132-42. 2012
    ..Monotherapy with monoclonal antibodies directed against the epidermal growth factor receptor, such as cetuximab and panitumumab, has recently been introduced in the management of metastatic colorectal cancer (mCRC) patients...
  2. ncbi request reprint Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
    Georgia Kourlaba
    The Stavros Niarchos Foundation Collaborative Center for Clinical Epidemiology and Outcomes Research CLEO, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
    BMC Health Serv Res 14:631. 2014
    ..p.m. in Greece, in comparison with current SoC alone...
  3. ncbi request reprint Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece
    Georgia Kourlaba
    National School of Public Health, Department of Health Services Management, Athens, Greece
    Appl Health Econ Health Policy 10:331-42. 2012
    ..Although clopidogrel seems to be superior to aspirin in terms of risk reduction for an atherothrombotic event, whether this clinical advantage is cost effective in Greece is unknown...
  4. ncbi request reprint Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis
    Georgia Kourlaba
    National School of Public Health, Department of Health Services Management, Athens, Greece
    Appl Health Econ Health Policy 10:261-71. 2012
    ..However, in the current climate of financial constraints, the effectiveness of a treatment should be considered in conjunction with its long-term economic costs to determine the best possible care...
  5. pmc Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study
    Thomas Paparrigopoulos
    Athens University Medical School, 1st Department of Psychiatry, Eginition Hospital, Athens, Greece
    BMC Psychiatry 11:41. 2011
    ....
  6. pmc Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece
    Nikos Maniadakis
    Department of Health Services Organization and Management, National School of Public Health, 196 Alexandras Avenue, Athens 11521, Greece
    BMC Health Serv Res 13:173. 2013
    ..To conduct an economic evaluation comparing agomelatine with other commonly used alternatives for treating patients with major depressive disorder (MDD) in Greece...
  7. ncbi request reprint The economic burden of atherothrombosis in Greece: results from the THESIS study
    Nikos Maniadakis
    Department of Health Services Organization and Management, National School of Public Health, 196 Alexandras Avenue 115 21, Athens, Greece
    Eur J Health Econ 14:655-65. 2013
    ..The total annual expenditures related to atherothrombosis, in Greece, were estimated to be €7.5 billion at the national level. The findings of the current study indicate the high economic burden of atherothrombosis in Greece...
  8. pmc Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece
    Vassilis Fragoulakis
    Department of Health Services Management, National School of Public Health, Athens
    Clinicoecon Outcomes Res 4:185-92. 2012
    ..The purpose of this study was to compare Gonal-F(®), a recombinant follicle-stimulating hormone, with Menopur(®), a highly purified human menopausal gonadotrophin (hpHMG) in assisted reproduction in Greece...
  9. pmc Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
    Vassilis Fragoulakis
    Department of Health Services and Management, National School of Public Health, Athens, Greece
    Clinicoecon Outcomes Res 4:135-43. 2012
    ....
  10. ncbi request reprint Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
    Charalampos Tzanetakos
    Department of Health Services Organisation and Management, National School of Public Health, 196 Alexandras Avenue, 11521 Athens, Greece
    BMC Health Serv Res 14:419. 2014
    ..To evaluate the long-term cost-effectiveness of liraglutide versus sitagliptin or exenatide, added to oral antidiabetic drug mono- or combination therapy respectively, in patients with Type 2 diabetes in Greece...
  11. ncbi request reprint The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review
    Georgia Kourlaba
    aThe Stavros Niarchos Foundation Collaborative Center for Clinical Epidemiology and Outcomes Research CLEO, National and Kapodistrian University of Athens School of Medicine bDepartment of Health Services Organisation and Management, National School of Public Health, Athens cCorporate Affairs and Market Access, LEO Pharmaceutical Products Hellas S A, Athens, Greece, dPatient Access, Global Patient Solutions Thrombosis, LEO Pharma A S, Ballerup, Denmark
    Blood Coagul Fibrinolysis 26:13-31. 2015
    ..The existing evidence assessed in the present review demonstrated the significant health and economic consequences of cancer-related VTE, which make a strong case for the importance of its proper and efficient prevention and management. ..
  12. ncbi request reprint Early evaluation of an organised mammography screening program in Greece 2004-2009
    Effie Simou
    Centre for the Prevention of Breast Cancer, General Oncology Hospital Agioi Anargyroi, 17, Laodikeias Ave, 11528 Ilisia, Athens, Greece
    Cancer Epidemiol 35:375-80. 2011
    ..The aim of the current study was to present early performance indicators of a breast cancer screening program in Greece...
  13. pmc Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece
    Vassilis Fragoulakis
    Department of Health Services Management, National School of Public Health, Athens
    Clinicoecon Outcomes Res 4:127-34. 2012
    ..To conduct an economic evaluation comparing Ferinject(®) (ferric carboxymaltose [FCM]) with Venofer(®) (iron sucrose [IS]) and CosmoFer(®) (low-molecular-weight iron dextran [LMWID]) in the management of iron deficiency anemia in Greece...
  14. pmc Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey
    Nikos Maniadakis
    Department of Health Services Management, National School of Public Health, Athens, Greece
    BMC Cardiovasc Disord 11:16. 2011
    ..The aim of this study was to estimate the prevalence of selected atherothrombotic risk factors and several clinical manifestations of atherothrombosis, as well as the utilization rates of selected vascular interventions in Greece...